-25% su tutto – fino al 31 OttobreSpedizione gratuita da $99
Biotech Peptides

Uso del prodotto: Questo prodotto è destinato esclusivamente alla ricerca.

Tutte le informazioni sui prodotti presenti su questo sito hanno scopo esclusivamente educativo. Qualsiasi forma di introduzione nel corpo di esseri umani o animali è severamente vietata dalla legge. Questo prodotto deve essere maneggiato solo da professionisti abilitati e qualificati. Non è un farmaco, un alimento o un cosmetico e non deve essere etichettato, utilizzato o presentato come tale.

Hexarelin (Examorelin) 2mg

Hexarelin (Examorelin) is a synthetic hexapeptide growth hormone secretagogue and one of the most potent GHS-R1a agonists identified.

Stessa formula affidabile. Nuovo look.

Durante il cambio di confezione potresti ricevere prodotti con l’etichetta precedente o con quella nuova. Formulazione, purezza e qualità restano esattamente le stesse, secondo i nostri standard.

Metodi di pagamento accettati
  • Carta di credito
  • Bonifico bancario (SEPA istantaneo)
  • Bonifico bancario (ACH)
  • Wise
  • Revolut
  • Zelle
  • Remitly
  • Western Union
  • Chime
  • Altri metodi

-25% su tutto – fino al 31 Ottobre
25% sui prezzi ordinari, in sostituzione degli altri saldi. Cumulabile solo con lo sconto crypto.

Spedizione

Spedizione in giornata per gli ordini USA effettuati entro le 12:00 EST.

Vedi le condizioni di spedizione →
Resi

Resi facili entro 30 giorni sui prodotti non aperti.

Vedi la politica di reso →
Testato in laboratorio

Ogni lotto è testato per purezza, potenza e qualità.

Vedi i risultati di laboratorio →
Assistenza

Hai una domanda? Scrivici su Telegram.

Apri la chat →

Hexarelin (Examorelin) is a synthetic hexapeptide growth hormone secretagogue and one of the most potent GHS-R1a agonists identified. Binding to GHS-R1a activates Gq/11-mediated phospholipase C signalling, resulting in IP3/DAG generation, intracellular calcium mobilization, and downstream secretagogue-associated signalling pathways.

Unlike other members of the GHRP class, Hexarelin also interacts with CD36 (scavenger receptor class B), providing a secondary signalling mechanism independent of GHS-R1a activation.

This dual receptor profile makes Hexarelin a valuable research tool for investigating GHS-R1a pharmacology, receptor-signalling dynamics, secretagogue potency relationships, CD36-mediated signalling pathways, and comparative peptide pharmacology.

Experimental studies have also utilized Hexarelin in investigations of receptor cross-talk, intracellular signalling networks, and peptide-receptor selectivity. Supplied as lyophilized preparation (2 mg/vial).

  • High Purity – 99% Purity Guaranteed
  • Independently Lab Tested
  • Research Grade Quality
  • For Laboratory Research Use Only

3D Molecular Structure

Drag to rotate · scroll to zoom
Loading 3D structure…
Hexarelin (Examorelin) 2mg1 vial | KIT (10 vials)
Chemical Formula C47H58N12O6
Synonyms Examorelin, EP-23905, MF-6003, His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2
Molar Mass 887.05 g/mol
CAS Number 140703-51-1
PubChem CID 6918297
Total Compound Content 2 mg per vial
Shelf Life 36 months
Hexarelin (His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2), also known as Examorelin, is a synthetic hexapeptide and one of the most potent growth hormone secretagogue receptor (GHS-R1a) agonists characterized. Binding to GHS-R1a activates Gq/11-mediated phospholipase C signalling, resulting in IP3/DAG generation, intracellular calcium mobilization, and downstream secretagogue-associated signalling pathways. Unlike other members of the GHRP class, Hexarelin additionally interacts with CD36, a scavenger receptor involved in lipid-sensing, cellular signalling, and metabolic regulation pathways. This dual GHS-R1a/CD36 pharmacology distinguishes Hexarelin from GHRP-2, GHRP-6, and Ipamorelin, making it a valuable research tool for investigating receptor-specific signalling mechanisms, secretagogue pharmacology, CD36-mediated pathways, receptor cross-talk, and comparative peptide biology. Experimental studies have utilized Hexarelin in GHS-R1a signalling research, CD36 pathway investigations, receptor-selectivity studies, and cellular signalling experiments designed to separate GHS-R1a-dependent from CD36-dependent effects. Plasma half-life is approximately 55 minutes. Supplied as lyophilised preparation (2 mg/vial). Independently third-party HPLC-tested; COA available per batch.

Every batch is independently lab tested for identity, purity and potency. View our lab testing program →

What is the CD36 receptor and why is Hexarelin's activity at this target significant?

CD36 (cluster of differentiation 36), also known as fatty acid translocase (FAT), is a class B scavenger receptor involved in lipid transport, fatty acid uptake, oxidized lipid recognition, and cellular metabolic signalling.

Hexarelin is unique among GHS-R1a agonists in that it also interacts with CD36, providing a second pharmacological mechanism independent of growth hormone secretagogue receptor activation.

This dual receptor profile makes Hexarelin a valuable research tool for investigating receptor-specific signalling pathways, metabolic regulation, lipid-sensing mechanisms, and the distinction between GHS-R1a-mediated and CD36-mediated biological effects.

How does Hexarelin compare to other GHS-R1a agonists in receptor potency studies?

Hexarelin is widely regarded as one of the most potent peptide agonists of GHS-R1a. Comparative pharmacology studies frequently utilize Hexarelin as a reference compound when evaluating receptor affinity, agonist efficacy, signalling kinetics, and downstream pathway activation among members of the GHRP class.

Its high receptor potency and well-characterized signalling profile have established it as a standard tool in GHS-R1a research and comparative secretagogue pharmacology.

What research applications are uniquely associated with Hexarelin?

In addition to its role in GHS-R1a signalling research, Hexarelin is used to investigate CD36-associated pathways, receptor cross-talk mechanisms, lipid-regulated signalling networks, cellular stress-response pathways, and comparative receptor pharmacology. The presence of both GHS-R1a and CD36 activity allows researchers to design experiments that differentiate receptor-specific signalling events and examine the interaction between distinct peptide-responsive pathways within the same experimental system.

Customer Reviews (12)

★★★★★ ★★★★★
5 / 5
5★
12
4★
0
3★
0
2★
0
1★
0
★★★★★ ★★★★★
Verified Buyer
Roy

Amazing products and fast shipping. I’m very happy with my purchase.

★★★★★ ★★★★★
Verified Buyer
Larry

The quality and speed of delivery impressed me. I'll be shopping here again.

★★★★★ ★★★★★
Verified Buyer
Carl

Worth every penny! High-quality products and fast shipping.

★★★★★ ★★★★★
Verified Buyer
B.B.

Highly satisfied with the support team and purity exceeded my expectations. A trustworthy supplier. My laboratory research results exceeded expectations.

★★★★★ ★★★★★
Verified Buyer
Mark

Great quality on the fast turnaround times, purity is outstanding. Will buy again. Results from my tests exceeded all expectations.